search
Back to results

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) (PILLAR)

Primary Purpose

Chronic Obstructive Pulmonary Disease

Status
Recruiting
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
CHF6001 1600µg
CHF6001 3200µg
Placebo
Roflumilast
Sponsored by
Chiesi Farmaceutici S.p.A.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Obstructive Pulmonary Disease focused on measuring COPD, chronic bronchitis, PDE4 inhibitor, anti-inflammatory respiratory drug, Tanimilast

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults aged ≥ 40 years, with COPD and with chronic bronchitis.
  • Current smokers or ex-smokers (history of ≥10 pack years).
  • Post-bronchodilator FEV1 <50% of the patient predicted normal value and FEV1/FVC ratio < 0.7.
  • At least, one moderate or severe COPD exacerbation in the previous year.
  • CAT score ≥10.
  • Subjects on regular maintenance triple therapy for at least 12 months.

Exclusion Criteria:

  • Subjects with current asthma.
  • Subjects with moderate or severe COPD exacerbation 4 weeks before study entry and randomisation
  • Subjects with known α-1 antitrypsin deficiency as the underlying cause of COPD.
  • Subjects with COPD emphysema or mixed phenotypes.
  • Subjects with known respiratory disorders other than COPD.
  • Subjects with lung volume reduction surgery.
  • Subjects with active cancer or a history of lung cancer.
  • Subjects under Roflumilast treatment within 6 months before study entry.
  • Subjects with a diagnosis of depression, generalised anxiety disorder, suicidal ideation.
  • Subjects with clinically significant cardiovascular condition.
  • Subjects with neurological disease.
  • Subjects with clinically significant laboratory abnormalities.
  • Subjects with moderate or severe hepatic impairment.

Sites / Locations

  • Chiesi Clinical Trial - Site 840635Recruiting
  • Chiesi Clinical Trial - Site 840614Recruiting
  • Chiesi Clinical Trial - Site 840670
  • Chiesi Clinical Trial - Site 840643Recruiting
  • Chiesi Clinical Trial - Site 840638
  • Chiesi Clinical Trial - Site 840684
  • Chiesi Clinical Trial - Site 840675
  • Chiesi Clinical Trial - Site 840666
  • Chiesi Clinical Trial - Site 840511Recruiting
  • Chiesi Clinical Trial - Site 840680
  • Chiesi Clinical Trial - Site 840531Recruiting
  • Chiesi Clinical Trial - Site 840636Recruiting
  • Chiesi Clinical Trial - Site 840688
  • Chiesi Clinical Trial - Site 840513Recruiting
  • Chiesi Clinical Trial - Site 840652Recruiting
  • Chiesi Clinical Trial - Site 840569Recruiting
  • Chiesi Clinical Trial - Site 840545Recruiting
  • Chiesi Clinical Trial - Site 840603
  • Chiesi Clinical Trial - Site 840587Recruiting
  • Chiesi Clinical Trial - Site 840568Recruiting
  • Chiesi Clinical Trial - Site840539
  • Chiesi Clinical Trial - Site 840554Recruiting
  • Chiesi Clinical Trial - Site 840625Recruiting
  • Chiesi Clinical Trial - Site 840572Recruiting
  • Chiesi Clinical Trial - Site 840637Recruiting
  • Chiesi Clinical Trial - Site 840685
  • Chiesi Clinical Trial - Site 840504Recruiting
  • Chiesi Clinical Trial - Site 840639Recruiting
  • Chiesi Clinical Trial - Site 840617Recruiting
  • Chiesi Clinical Trial - Site 840514Recruiting
  • Chiesi Clinical Trial - Site 840509Recruiting
  • Chiesi Clinical Trial - Site 840674
  • Chiesi Clinical Trial - Site 840506Recruiting
  • Chiesi Clinical Trial - Site 840608Recruiting
  • Chiesi Clinical Trial - Site 840624Recruiting
  • Chiesi Clinical Trial - Site 840596Recruiting
  • Chiesi Clinical Trial - Site 840556Recruiting
  • Chiesi Clinical Trial - Site 840507Recruiting
  • Chiesi Clinical Trial - Site 840519Recruiting
  • Chiesi Clinical Trial - Site 840505Recruiting
  • Chiesi Clinical Trial - Site 840644Recruiting
  • Chiesi Clinical Trial - Site 840557Recruiting
  • Chiesi Clinical Trial - Site 840588Recruiting
  • Chiesi Clinical Trial - Site 840618Recruiting
  • Chiesi Clinical Trial - Site 840525Recruiting
  • Chiesi Clinical Trial - Site 840656Recruiting
  • Chiesi Clinical Trial - Site 840622Recruiting
  • Chiesi Clinical Trial - Site 840537Recruiting
  • Chiesi Clinical Trial - Site 840503Recruiting
  • Chiesi Clinical Trial - Site 840630Recruiting
  • Chiesi Clinical Trial - Site 840524Recruiting
  • Chiesi Clinical Trial - Site 840563Recruiting
  • Chiesi Clinical Trial - Site 840502Recruiting
  • Chiesi Clinical Trial - Site 840550Recruiting
  • Chiesi Clinical Trial - Site 840527Recruiting
  • Chiesi Clinical Trial - Site 840654Recruiting
  • Chiesi Clinical Trial - Site 840567
  • Chiesi Clinical Trial - Site 840632Recruiting
  • Chiesi Clinical Trial - Site 840542Recruiting
  • Chiesi Clinical Trial - Site 840564Recruiting
  • Chiesi Clinical Trial - Site 840672
  • Chiesi Clinical Trial - Site 840645
  • Chiesi Clinical Trial - Site 840661
  • Chiesi Clinical Trial - Site 840687
  • Chiesi Clinical Trial - Site 840657Recruiting
  • Chiesi Clinical Trial - Site 840641Recruiting
  • Chiesi Clinical Trial - Site 840541Recruiting
  • Chiesi Clinical Trial - Site 840669Recruiting
  • Chiesi Clinical Trial - Site 840686
  • Chiesi Clinical Trial - Site 840529Recruiting
  • Chiesi Clinical Trial - Site 840626
  • Chiesi Clinical Trial - Site 840604Recruiting
  • Chiesi Clinical Trial - Site 840667
  • Chiesi Clinical Trial - Site 840678
  • Chiesi Clinical Trial - Site 840520
  • Chiesi Clinical Trial - Site 840664
  • Chiesi Clinical Trial - Site 840610Recruiting
  • Chiesi Clinical Trial - Site 840659Recruiting
  • Chiesi Clinical Trial - Site 840540Recruiting
  • Chiesi Clinical Trial - Site 840523Recruiting
  • Chiesi Clinical Trial - Site 840621Recruiting
  • Chiesi Clinical Trial - Site 840627Recruiting
  • Chiesi Clinical Trial - Site 840647
  • Chiesi Clinical Trial - Site 840646Recruiting
  • Chiesi Clinical Trial - Site 840668
  • Chiesi Clinical Trial - Site 840671
  • Chiesi Clinical Trial - Site 840683
  • Chiesi Clinical Trial - Site 840578Recruiting
  • Chiesi Clinical Trial - Site 840592Recruiting
  • Chiesi Clinical Trial - Site 840528Recruiting
  • Chiesi Clinical Trial - Site 840598
  • Chiesi Clinical Trial - Site 840660
  • Chiesi Clinical Trial - Site 840546
  • Chiesi Clinical Trial - Site 840553Recruiting
  • Chiesi Clinical Trial - Site 840535
  • Chiesi Clinical Trial - Site 840634Recruiting
  • Chiesi Clinical Trial - Site 840566Recruiting
  • Chiesi Clinical Trial - Site 840574Recruiting
  • Chiesi Clinical Trial - Site 840551Recruiting
  • Chiesi Clinical Trial - Site 840575Recruiting
  • Chiesi Clinical Trial - Site 840663Recruiting
  • Chiesi Clinical Trial - Site 840609Recruiting
  • Chiesi Clinical Trial - Site 840673
  • Chiesi Clinical Trial - Site 840681
  • Chiesi Clinical Trial - Site 840597
  • Chiesi Clinical Trial - Site 840600Recruiting
  • Chiesi Clinical Trial - Site 840552
  • Chiesi Clinical Trial - Site 840526Recruiting
  • Chiesi Clinical Trial - Site 840631
  • Chiesi Clinical Trial - Site 840562Recruiting
  • Chiesi Clinical Trial - Site 840532Recruiting
  • Chiesi Clinical Trial - Site 32515Recruiting
  • Chiesi Clinical Trial - Site 32565Recruiting
  • Chiesi Clinical Trial - Site 32514Recruiting
  • Chiesi Clinical Trial - Site 32567Recruiting
  • Chiesi Clinical Trial - Site 32510Recruiting
  • Chiesi Clinical Trial - Site 32507Recruiting
  • Chiesi Clinical Trial - Site 32503Recruiting
  • Chiesi Clinical Trial - Site 32509Recruiting
  • Chiesi Clinical Trial - Site 32508Recruiting
  • Chiesi Clinical Trial - Site 32501Recruiting
  • Chiesi Clinical Trial - Site 32562Recruiting
  • Chiesi Clinical Trial - Site 32505Recruiting
  • Chiesi Clinical Trial - Site 32511Recruiting
  • Chiesi Clinical Trial - Site 32513Recruiting
  • Chiesi Clinical Trial - Site 32506Recruiting
  • Chiesi Clinical Trial - Site 32553Recruiting
  • Chiesi Clinical Trial - Site 32512Recruiting
  • Chiesi Clinical Trial - Site 32551Recruiting
  • Chiesi Clinical Trial - Site 32561
  • Chiesi Clinical Trial - Site 32564Recruiting
  • Chiesi Clinical Trial - Site 32566Recruiting
  • Chiesi Clinical Trial - Site 32556Recruiting
  • Chiesi Clinical Trial - Site 40502Recruiting
  • Chiesi Clinical Trial - Site 40504Recruiting
  • Chiesi Clinical Trial - Site 40501Recruiting
  • Chiesi Clinical Trial - Site 40503
  • Chiesi Clinical Trial - Site 70553
  • Chiesi Clinical Trial - Site 70555Recruiting
  • Chiesi Clinical Trial - Site 70554
  • Chiesi Clinical Trial - Site 70557Recruiting
  • Chiesi Clinical Trial - Site 70556Recruiting
  • Chiesi Clinical Trial - Site 70560Recruiting
  • Chiesi Clinical Trial - Site 70562
  • Chiesi Clinical Trial - Site 70559Recruiting
  • Chiesi Clinical Trial - Site 70561
  • Chiesi Clinical Trial - Site 70551
  • Chiesi Clinical Trial - Site 70558
  • Chiesi Clinical Trial - Site 70563Recruiting
  • Chiesi Clinical Trial - Site 70552
  • Chiesi Clinical Trial - Site 100535Recruiting
  • Chiesi Clinical Trial - Site 100534Recruiting
  • Chiesi Clinical Trial - Site 100525Recruiting
  • Chiesi Clinical Trial - Site 100523Recruiting
  • Chiesi Clinical Trial - Site 100533Recruiting
  • Chiesi Clinical Trial - Site 100527Recruiting
  • Chiesi Clinical Trial - Site 100515Recruiting
  • Chiesi Clinical Trial - Site 100532Recruiting
  • Chiesi Clinical Trial - Site 100522Recruiting
  • Chiesi Clinical Trial - Site 100529Recruiting
  • Chiesi Clinical Trial - Site 100537Recruiting
  • Chiesi Clinical Trial - Site 100512Recruiting
  • Chiesi Clinical Trial - Site 100516Recruiting
  • Chiesi Clinical Trial - Site 100536Recruiting
  • Chiesi Clinical Trial - Site 100501Recruiting
  • Chiesi Clinical Trial - Site 100509Recruiting
  • Chiesi Clinical Trial - Site 100514Recruiting
  • Chiesi Clinical Trial - Site 100517Recruiting
  • Chiesi Clinical Trial - Site 100518Recruiting
  • Chiesi Clinical Trial - Site 100530Recruiting
  • Chiesi Clinical Trial - Site 100531Recruiting
  • Chiesi Clinical Trial - Site 100538Recruiting
  • Chiesi Clinical Trial - Site 100524Recruiting
  • Chiesi Clinical Trial - Site 100519Recruiting
  • Chiesi Clinical Trial - Site 100557Recruiting
  • Chiesi Clinical Trial - Site 152506
  • Chiesi Clinical Trial - Site 152507Recruiting
  • Chiesi Clinical Trial - Site 152503Recruiting
  • Chiesi Clinical Trial - Site 152504Recruiting
  • Chiesi Clinical Trial - Site 152508Recruiting
  • Chiesi Clinical Trial - Site 152509Recruiting
  • Chiesi Clinical Trial - Site 152501Recruiting
  • Chiesi Clinical Trial - Site 191562
  • Chiesi Clinical Trial - Site 191552Recruiting
  • Chiesi Clinical Trial - Site 191557
  • Chiesi Clinical Trial - Site 191561Recruiting
  • Chiesi Clinical Trial - Site 191563
  • Chiesi Clinical Trial - Site 191553Recruiting
  • Chiesi Clinical Trial - Site 191558
  • Chiesi Clinical Trial - Site 191555
  • Chiesi Clinical Trial - Site 191551Recruiting
  • Chiesi Clinical Trial - Site 191554
  • Chiesi Clinical Trial - Site 191556Recruiting
  • Chiesi Clinical Trial - Site 191559
  • Chiesi Clinical Trial - Site 191560Recruiting
  • Chiesi Clinical Trial - Site 203551Recruiting
  • Chiesi Clinical Trial - Site 203518Recruiting
  • Chiesi Clinical Trial - Site 203501Recruiting
  • Chiesi Clinical Trial - Site 203504Recruiting
  • Chiesi Clinical Trial - Site 203516Recruiting
  • Chiesi Clinical Trial - Site 203517Recruiting
  • Chiesi Clinical Trial - Site 203505Recruiting
  • Chiesi Clinical Trial - Site 203507Recruiting
  • Chiesi Clinical Trial - Site 203513Recruiting
  • Chiesi Clinical Trial - Site 203515Recruiting
  • Chiesi Clinical Trial - Site 372553
  • Chiesi Clinical Trial - Site 372551
  • Chiesi Clinical Trial - Site 372552Recruiting
  • Chiesi Clinical Trial - Site 276505Recruiting
  • Chiesi Clinical Trial - Site 276506Recruiting
  • Chiesi Clinical Trial - Site 276510Recruiting
  • Chiesi Clinical Trial - Site 276511Recruiting
  • Chiesi Clinical Trial - Site 276515
  • Chiesi Clinical Trial - Site 276556
  • Chiesi Clinical Trial - Site 276509Recruiting
  • Chiesi Clinical Trial - Site 276503Recruiting
  • Chiesi Clinical Trial - Site 276504Recruiting
  • Chiesi Clinical Trial - Site 276557
  • Chiesi Clinical Trial - Site 276501Recruiting
  • Chiesi Clinical Trial - Site 276513Recruiting
  • Chiesi Clinical Trial - Site 276514
  • Chiesi Clinical Trial - Site 276558
  • Chiesi Clinical Trial - Site 276517
  • Chiesi Clinical Trial - Site 276502Recruiting
  • Chiesi Clinical Trial - Site 276516Recruiting
  • Chiesi Clinical Trial - Site 276551Recruiting
  • Chiesi Clinical Trial - Site 276507Recruiting
  • Chiesi Clinical Trial - Site 276508Recruiting
  • Chiesi Clinical Trial - Site 276518Recruiting
  • Chiesi Clinical Trial - Site 300506Recruiting
  • Chiesi Clinical Trial - Site 300504Recruiting
  • Chiesi Clinical Trial - Site 300501Recruiting
  • Chiesi Clinical Trial - Site 300503Recruiting
  • Chiesi Clinical Trial - Site 300505Recruiting
  • Chiesi Clinical Trial - Site 300507Recruiting
  • Chiesi Clinical Trial - Site 348506Recruiting
  • Chiesi Clinical Trial - Site 348501Recruiting
  • Chiesi Clinical Trial - Site 348505Recruiting
  • Chiesi Clinical Trial - Site 348512Recruiting
  • Chiesi Clinical Trial - Site 348508Recruiting
  • Chiesi Clinical Trial - Site 348509Recruiting
  • Chiesi Clinical Trial - Site 348507Recruiting
  • Chiesi Clinical Trial - Site 348513Recruiting
  • Chiesi Clinical Trial - Site 348552Recruiting
  • Chiesi Clinical Trial - Site 348510Recruiting
  • Chiesi Clinical Trial - Site 348503Recruiting
  • Chiesi Clinical Trial - Site 348515
  • Chiesi Clinical Trial - Site 376502Recruiting
  • Chiesi Clinical Trial - Site 376501Recruiting
  • Chiesi Clinical Trial - Site 376511
  • Chiesi Clinical Trial - Site 376508Recruiting
  • Chiesi Clinical Trial - Site 376510
  • Chiesi Clinical Trial - Site 376503Recruiting
  • Chiesi Clinical Trial - Site 376506Recruiting
  • Chiesi Clinical Trial - Site 376507Recruiting
  • Chiesi Clinical Trial - Site 376504Recruiting
  • Chiesi Clinical Trial - Site 376509
  • Chiesi Clinical Trial - Site 408556
  • Chiesi Clinical Trial - Site 408551
  • Chiesi Clinical Trial - Site 408560
  • Chiesi Clinical Trial - Site 408554
  • Chiesi Clinical Trial - Site 408559
  • Chiesi Clinical Trial - Site 408557
  • Chiesi Clinical Trial - Site 408558
  • Chiesi Clinical Trial - Site 408555
  • Chiesi Clinical Trial - Site 408552
  • Chiesi Clinical Trial - Site 408553
  • Chiesi Clinical Trial - Site 408561
  • Chiesi Clinical Trial - Site 371557Recruiting
  • Chiesi Clinical Trial - Site 371553Recruiting
  • Chiesi Clinical Trial - Site 371554Recruiting
  • Chiesi Clinical Trial - Site 371555Recruiting
  • Chiesi Clinical Trial - Site 371551Recruiting
  • Chiesi Clinical Trial - Site 371552Recruiting
  • Chiesi Clinical Trial - Site 371558Recruiting
  • Chiesi Clinical Trial - Site 371556Recruiting
  • Chiesi Clinical Trial - Site 484502Recruiting
  • Chiesi Clinical Trial - Site 484510Recruiting
  • Chiesi Clinical Trial - Site 484505
  • Chiesi Clinical Trial - Site 484506Recruiting
  • Chiesi Clinical Trial - Site 484501
  • Chiesi Clinical Trial - Site 484507Recruiting
  • Chiesi Clinical Trial - Site 484509Recruiting
  • Chiesi Clinical Trial - Site 484503Recruiting
  • Chiesi Clinical Trial - Site 484511
  • Chiesi Clinical Trial - Site 484504
  • Chiesi Clinical Trial - Site 528501
  • Chiesi Clinical Trial - Site 528504Recruiting
  • Chiesi Clinical Trial - Site 528502Recruiting
  • Chiesi Clinical Trial - Site 528505Recruiting
  • Chiesi Clinical Trial - Site 554504Recruiting
  • Chiesi Clinical Trial - Site 554502Recruiting
  • Chiesi Clinical Trial - Site 554503Recruiting
  • Chiesi Clinical Trial - Site 807555Recruiting
  • Chiesi Clinical Trial - Site 807559
  • Chiesi Clinical Trial - Site 807557Recruiting
  • Chiesi Clinical Trial - Site 807553Recruiting
  • Chiesi Clinical Trial - Site 807552Recruiting
  • Chiesi Clinical Trial - Site 807554Recruiting
  • Chiesi Clinical Trial - Site 807556Recruiting
  • Chiesi Clinical Trial - Site 616518Recruiting
  • Chiesi Clinical Trial - Site 616504Recruiting
  • Chiesi Clinical Trial - Site 616515Recruiting
  • Chiesi Clinical Trial - Site 616522Recruiting
  • Chiesi Clinical Trial - Site 616514Recruiting
  • Chiesi Clinical Trial - Site 616509Recruiting
  • Chiesi Clinical Trial - Site 616511Recruiting
  • Chiesi Clinical Trial - Site 616519Recruiting
  • Chiesi Clinical Trial - Site 616506Recruiting
  • Chiesi Clinical Trial - Site 616508Recruiting
  • Chiesi Clinical Trial - Site 616501Recruiting
  • Chiesi Clinical Trial - Site 616502Recruiting
  • Chiesi Clinical Trial - Site 616554Recruiting
  • Chiesi Clinical Trial - Site 616503Recruiting
  • Chiesi Clinical Trial - Site 616523Recruiting
  • Chiesi Clinical Trial - Site 642510
  • Chiesi Clinical Trial - Site 642551
  • Chiesi Clinical Trial - Site 642506Recruiting
  • Chiesi Clinical Trial - Site 642508
  • Chiesi Clinical Trial - Site 642502
  • Chiesi Clinical Trial - Site 642504
  • Chiesi Clinical Trial - Site 642554
  • Chiesi Clinical Trial - Site 642512
  • Chiesi Clinical Trial - Site 642501Recruiting
  • Chiesi Clinical Trial - Site 642509Recruiting
  • Chiesi Clinical Trial - Site 642511
  • Chiesi Clinical Trial - Site 642514Recruiting
  • Chiesi Clinical Trial - Site 642503
  • Chiesi Clinical Trial - Site 642513Recruiting
  • Chiesi Clinical Trial - Site 642507Recruiting
  • Chiesi Clinical Trial - Site 642515
  • Chiesi Clinical Trial - Site 642505
  • Chiesi Clinical Trial - Site 643517Recruiting
  • Chiesi Clinical Trial - Site 643513Recruiting
  • Chiesi Clinical Trial - Site 643528Recruiting
  • Chiesi Clinical Trial - Site 643516Recruiting
  • Chiesi Clinical Trial - Site 643503Recruiting
  • Chiesi Clinical Trial - Site 643505Recruiting
  • Chiesi Clinical Trial - Site 643506
  • Chiesi Clinical Trial - Site 643508Recruiting
  • Chiesi Clinical Trial - Site 643511Recruiting
  • Chiesi Clinical Trial - Site 643514Recruiting
  • Chiesi Clinical Trial - Site 643519Recruiting
  • Chiesi Clinical Trial - Site 643531Recruiting
  • Chiesi Clinical Trial - Site 643510Recruiting
  • Chiesi Clinical Trial - Site 643512
  • Chiesi Clinical Trial - Site 643520Recruiting
  • Chiesi Clinical Trial - Site 643504Recruiting
  • Chiesi Clinical Trial - Site 643515Recruiting
  • Chiesi Clinical Trial - Site 643525Recruiting
  • Chiesi Clinical Trial - Site 643521Recruiting
  • Chiesi Clinical Trial - Site 643502Recruiting
  • Chiesi Clinical Trial - Site 643524Recruiting
  • Chiesi Clinical Trial - Site 643507
  • Chiesi Clinical Trial - Site 643518
  • Chiesi Clinical Trial - Site 688552
  • Chiesi Clinical Trial - Site 688553
  • Chiesi Clinical Trial - Site 688555
  • Chiesi Clinical Trial - Site 688557
  • Chiesi Clinical Trial - Site 688558
  • Chiesi Clinical Trial - Site 688559
  • Chiesi Clinical Trial - Site 688561
  • Chiesi Clinical Trial - Site 688569
  • Chiesi Clinical Trial - Site 688570
  • Chiesi Clinical Trial - Site 688556
  • Chiesi Clinical Trial - Site 688562
  • Chiesi Clinical Trial - Site 688554
  • Chiesi Clinical Trial - Site 688568
  • Chiesi Clinical Trial - Site 688567
  • Chiesi Clinical Trial - Site 688560
  • Chiesi Clinical Trial - Site 688551Recruiting
  • Chiesi Clinical Trial - Site 688564
  • Chiesi Clinical Trial - Site 688566
  • Chiesi Clinical Trial - Site 688571
  • Chiesi Clinical Trial - Site 688563Recruiting
  • Chiesi Clinical Trial - Site 688565
  • Chiesi Clinical Trial - Site 703501Recruiting
  • Chiesi Clinical Trial - Site 703503Recruiting
  • Chiesi Clinical Trial - Site 703502Recruiting
  • Chiesi Clinical Trial - Site 724503
  • Chiesi Clinical Trial - Site 724501
  • Chiesi Clinical Trial - Site 724505
  • Chiesi Clinical Trial - Site 724551
  • Chiesi Clinical Trial - Site 724504
  • Chiesi Clinical Trial - Site 724502
  • Chiesi Clinical Trial - Site 792512Recruiting
  • Chiesi Clinical Trial - Site 792510Recruiting
  • Chiesi Clinical Trial - Site 792507Recruiting
  • Chiesi Clinical Trial - Site 792514Recruiting
  • Chiesi Clinical Trial - Site 792513Recruiting
  • Chiesi Clinical Trial - Site 792506Recruiting
  • Chiesi Clinical Trial - Site 792508Recruiting
  • Chiesi Clinical Trial - Site 792511Recruiting
  • Chiesi Clinical Trial - Site 792551Recruiting
  • Chiesi Clinical Trial - Site 804522
  • Chiesi Clinical Trial - Site 804502Recruiting
  • Chiesi Clinical Trial - Site 804504
  • Chiesi Clinical Trial - Site 804506Recruiting
  • Chiesi Clinical Trial - Site 804509Recruiting
  • Chiesi Clinical Trial - Site 804505Recruiting
  • Chiesi Clinical Trial - Site 804503Recruiting
  • Chiesi Clinical Trial - Site 804511
  • Chiesi Clinical Trial - Site 804520
  • Chiesi Clinical Trial - Site 804501Recruiting
  • Chiesi Clinical Trial - Site 804508Recruiting
  • Chiesi Clinical Trial - Site 804512Recruiting
  • Chiesi Clinical Trial - Site 804516Recruiting
  • Chiesi Clinical Trial - Site 804518Recruiting
  • Chiesi Clinical Trial - Site 804521Recruiting
  • Chiesi Clinical Trial - Site 804527Recruiting
  • Chiesi Clinical Trial - Site 804515Recruiting
  • Chiesi Clinical Trial - Site 804517Recruiting
  • Chiesi Clinical Trial - Site 804528
  • Chiesi Clinical Trial - Site 826510Recruiting
  • Chiesi Clinical Trial - Site 826509Recruiting
  • Chiesi Clinical Trial - Site 826511Recruiting
  • Chiesi Clinical Trial - Site 826512Recruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Placebo Comparator

Active Comparator

Arm Label

CHF6001 1600µg

CHF6001 3200µg

Placebo

Roflumilast

Arm Description

Outcomes

Primary Outcome Measures

The number of moderate and severe exacerbations occurring during the planned 52-week treatment period.
Moderate or severe exacerbation is defined by symptomatic worsening of COPD: Moderate : requiring use of systemic corticosteroids (oral/IV/IM corticosteroids), and/or use of antibiotics Severe : requiring hospitalisation or resulting in death

Secondary Outcome Measures

The time to first moderate or severe exacerbation.
The annual rate of severe exacerbations.
The time to first severe exacerbation.
The number of all on-treatment severe exacerbations.
The number of all on-treatment exacerbations requiring systemic corticosteroids.
Change from baseline (pre-dose Visit 2) in pre-dose FEV1, at week 52.
Change from baseline in SGRQ total and domain scores at week 52.
SGRQ response (change from baseline SGRQ total score ≤ -4) at week 52.
Change from baseline to last inter-visit period (week 40-52) in E-RS Total and subscale scores.
E-RS response (change from baseline E-RS Total score ≤ -2) at week 52.
Change from baseline to last inter-visit period (week 40-52) in the percentage of days without intake of rescue medication and in the average rescue medication use (number of puffs).
Time to study medication discontinuation for any reason.
Time to moderate or severe exacerbation or study medication discontinuation due to any adverse event, lack of efficacy or death (composite endpoint) and time to study medication discontinuation component.
Time to first moderate/severe exacerbation or study medication discontinuation due to any class-related AE, lack of efficacy, or death (composite endpoint) and time to study medication discontinuation component.
Key Secondary Variable: Change from baseline in SGRQ Total score at week 52

Full Information

First Posted
November 16, 2020
Last Updated
August 31, 2023
Sponsor
Chiesi Farmaceutici S.p.A.
search

1. Study Identification

Unique Protocol Identification Number
NCT04636814
Brief Title
A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)
Acronym
PILLAR
Official Title
A 52-week, Randomized, Double-blind, Double-dummy, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg), Parallel Group, Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI add-on to Maintenance Triple Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis.
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 12, 2021 (Actual)
Primary Completion Date
September 18, 2027 (Anticipated)
Study Completion Date
September 25, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Chiesi Farmaceutici S.p.A.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease
Keywords
COPD, chronic bronchitis, PDE4 inhibitor, anti-inflammatory respiratory drug, Tanimilast

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
3980 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
CHF6001 1600µg
Arm Type
Experimental
Arm Title
CHF6001 3200µg
Arm Type
Experimental
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Title
Roflumilast
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
CHF6001 1600µg
Intervention Description
CHF6001 400µg, 2 inhalations bid (total daily dose of 1600µg) and Roflumilast matching placebo, 1 tablet once daily
Intervention Type
Drug
Intervention Name(s)
CHF6001 3200µg
Intervention Description
CHF6001 800µg, 2 inhalations bid (total daily dose of 3200µg) and Roflumilast matching placebo, 1 tablet once daily
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
CHF6001 matching placebo, 2 inhalations bid and Roflumilast matching placebo, 1 tablet once daily
Intervention Type
Drug
Intervention Name(s)
Roflumilast
Intervention Description
- 1 tablet of Roflumilast (Daliresp®), 250µg, once daily during the first 4 weeks of treatment then 1 tablet of Roflumilast (Daliresp®), 500µg, once daily for the remaining treatment period and CHF6001 matching placebo, 2 inhalations bid
Primary Outcome Measure Information:
Title
The number of moderate and severe exacerbations occurring during the planned 52-week treatment period.
Description
Moderate or severe exacerbation is defined by symptomatic worsening of COPD: Moderate : requiring use of systemic corticosteroids (oral/IV/IM corticosteroids), and/or use of antibiotics Severe : requiring hospitalisation or resulting in death
Time Frame
Up to 52 weeks
Secondary Outcome Measure Information:
Title
The time to first moderate or severe exacerbation.
Time Frame
Up to 52 weeks
Title
The annual rate of severe exacerbations.
Time Frame
Up to 52 weeks
Title
The time to first severe exacerbation.
Time Frame
Up to 52 weeks
Title
The number of all on-treatment severe exacerbations.
Time Frame
Up to 52 weeks
Title
The number of all on-treatment exacerbations requiring systemic corticosteroids.
Time Frame
Up to 52 weeks
Title
Change from baseline (pre-dose Visit 2) in pre-dose FEV1, at week 52.
Time Frame
At week 52
Title
Change from baseline in SGRQ total and domain scores at week 52.
Time Frame
At week 52
Title
SGRQ response (change from baseline SGRQ total score ≤ -4) at week 52.
Time Frame
At week 52
Title
Change from baseline to last inter-visit period (week 40-52) in E-RS Total and subscale scores.
Time Frame
Up to 52 weeks
Title
E-RS response (change from baseline E-RS Total score ≤ -2) at week 52.
Time Frame
At week 52
Title
Change from baseline to last inter-visit period (week 40-52) in the percentage of days without intake of rescue medication and in the average rescue medication use (number of puffs).
Time Frame
Up to 52 weeks
Title
Time to study medication discontinuation for any reason.
Time Frame
Up to 52 weeks
Title
Time to moderate or severe exacerbation or study medication discontinuation due to any adverse event, lack of efficacy or death (composite endpoint) and time to study medication discontinuation component.
Time Frame
Up to 52 weeks
Title
Time to first moderate/severe exacerbation or study medication discontinuation due to any class-related AE, lack of efficacy, or death (composite endpoint) and time to study medication discontinuation component.
Time Frame
Up to 52 weeks
Title
Key Secondary Variable: Change from baseline in SGRQ Total score at week 52
Time Frame
At week 52

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults aged ≥ 40 years, with COPD and with chronic bronchitis. Current smokers or ex-smokers (history of ≥10 pack years). Post-bronchodilator FEV1 <50% of the patient predicted normal value and FEV1/FVC ratio < 0.7. At least, one moderate or severe COPD exacerbation in the previous year. CAT score ≥10. Subjects on regular maintenance triple therapy for at least 12 months. Exclusion Criteria: Subjects with current asthma. Subjects with moderate or severe COPD exacerbation 4 weeks before study entry and randomisation Subjects with known α-1 antitrypsin deficiency as the underlying cause of COPD. Subjects with primary diagnosis of emphysema not related to COPD. Subjects with known respiratory disorders other than COPD. Subjects with lung volume reduction surgery. Subjects with active cancer or a history of lung cancer. Subjects under Roflumilast treatment within 6 months before study entry. Subjects with a diagnosis of depression, generalised anxiety disorder, suicidal ideation. Subjects with clinically significant cardiovascular condition. Subjects with neurological disease. Subjects with clinically significant laboratory abnormalities. Subjects with moderate or severe hepatic impairment.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chiesi Clinical Trial info
Phone
+ 39 0521 279 715
Email
clinicaltrials_info@chiesi.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fernando J. MARTINEZ, Prof.
Organizational Affiliation
Weill Cornell Medical College, New York Presbyterian Hospital, 1305 York avenue box 96 New York 10021 USA
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chiesi Clinical Trial - Site 840635
City
Andalusia
State/Province
Alabama
ZIP/Postal Code
36420-5310
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840614
City
Foley
State/Province
Alabama
ZIP/Postal Code
36535-2248
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840670
City
Guntersville
State/Province
Alabama
ZIP/Postal Code
35976-2206
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840643
City
Saraland
State/Province
Alabama
ZIP/Postal Code
36571-3014
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840638
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85018-5434
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840684
City
Conway
State/Province
Arkansas
ZIP/Postal Code
72032
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840675
City
Laguna Hills
State/Province
California
ZIP/Postal Code
92653-5509
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840666
City
Los Angeles
State/Province
California
ZIP/Postal Code
90017-5649
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840511
City
Newport Beach
State/Province
California
ZIP/Postal Code
92663-3661
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840680
City
Northridge
State/Province
California
ZIP/Postal Code
91324-6200
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840531
City
Westminster
State/Province
California
ZIP/Postal Code
92708
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840636
City
Centennial
State/Province
Colorado
ZIP/Postal Code
80112-1406
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840688
City
Lakewood
State/Province
Colorado
ZIP/Postal Code
80228
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840513
City
Chiefland
State/Province
Florida
ZIP/Postal Code
32626
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840652
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33756
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840569
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33765-2103
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840545
City
Coral Gables
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840603
City
Cutler Bay
State/Province
Florida
ZIP/Postal Code
33144-2566
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840587
City
Cutler Bay
State/Province
Florida
ZIP/Postal Code
33189-1230
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840568
City
Cutler Bay
State/Province
Florida
ZIP/Postal Code
33189
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site840539
City
Daytona Beach
State/Province
Florida
ZIP/Postal Code
33470-9216
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840554
City
DeBary
State/Province
Florida
ZIP/Postal Code
32713-2260
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840625
City
Doral
State/Province
Florida
ZIP/Postal Code
33014-2426
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840572
City
Doral
State/Province
Florida
ZIP/Postal Code
33122-1902
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840637
City
Hialeah Gardens
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840685
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33010-4103
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840504
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33012-3618
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840639
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33015-2952
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840617
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016-2753
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840514
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33186-5331
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840509
City
Hollywood
State/Province
Florida
ZIP/Postal Code
33021
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840674
City
Loxahatchee Groves
State/Province
Florida
ZIP/Postal Code
33470
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840506
City
Miami Gardens
State/Province
Florida
ZIP/Postal Code
33014-6426
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840608
City
Miami Lakes
State/Province
Florida
ZIP/Postal Code
33014-2425
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840624
City
Miami
State/Province
Florida
ZIP/Postal Code
33125-5114
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840596
City
Miami
State/Province
Florida
ZIP/Postal Code
33126-1921
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840556
City
Miami
State/Province
Florida
ZIP/Postal Code
33126-1926
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840507
City
Miami
State/Province
Florida
ZIP/Postal Code
33144-2100
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840519
City
Miami
State/Province
Florida
ZIP/Postal Code
33144-4273
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840505
City
Miami
State/Province
Florida
ZIP/Postal Code
33144-5037
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840644
City
Miami
State/Province
Florida
ZIP/Postal Code
33144
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840557
City
Miami
State/Province
Florida
ZIP/Postal Code
33155-1694
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840588
City
Miami
State/Province
Florida
ZIP/Postal Code
33155-4630
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840618
City
Miami
State/Province
Florida
ZIP/Postal Code
33155-6538
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840525
City
Miami
State/Province
Florida
ZIP/Postal Code
33155-6541
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840656
City
Miami
State/Province
Florida
ZIP/Postal Code
33155-6542
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840622
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840537
City
Miami
State/Province
Florida
ZIP/Postal Code
33165-2075
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840503
City
Miami
State/Province
Florida
ZIP/Postal Code
33175-3598
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840630
City
Miami
State/Province
Florida
ZIP/Postal Code
33185
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840524
City
Orlando
State/Province
Florida
ZIP/Postal Code
32807-3555
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840563
City
Orlando
State/Province
Florida
ZIP/Postal Code
32825
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840502
City
Pembroke Pines
State/Province
Florida
ZIP/Postal Code
33024-3618
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840550
City
Pembroke Pines
State/Province
Florida
ZIP/Postal Code
33024-6442
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840527
City
Pompano Beach
State/Province
Florida
ZIP/Postal Code
33064-3547
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840654
City
South Miami
State/Province
Florida
ZIP/Postal Code
33143-4960
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840567
City
Tampa
State/Province
Florida
ZIP/Postal Code
33613-3740
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840632
City
Winter Park
State/Province
Florida
ZIP/Postal Code
32789
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840542
City
Adairsville
State/Province
Georgia
ZIP/Postal Code
30103-2438
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840564
City
Valdosta
State/Province
Georgia
ZIP/Postal Code
31605-1096
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840672
City
Zachary
State/Province
Louisiana
ZIP/Postal Code
70791-4010
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840645
City
Annapolis
State/Province
Maryland
ZIP/Postal Code
21401
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840661
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21224-6821
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840687
City
Flint
State/Province
Michigan
ZIP/Postal Code
48532
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840657
City
Troy
State/Province
Michigan
ZIP/Postal Code
48085
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840641
City
Saint Charles
State/Province
Missouri
ZIP/Postal Code
63301-2835
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840541
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63141
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840669
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63141
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840686
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68178
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840529
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89106-4159
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840626
City
Bronx
State/Province
New York
ZIP/Postal Code
10455
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840604
City
Bronx
State/Province
New York
ZIP/Postal Code
10468-6401
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840667
City
Buffalo
State/Province
New York
ZIP/Postal Code
14203-1070
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840678
City
New Windsor
State/Province
New York
ZIP/Postal Code
12553-7754
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840520
City
New York
State/Province
New York
ZIP/Postal Code
10021-0005
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840664
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28210-0106
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840610
City
Denver
State/Province
North Carolina
ZIP/Postal Code
28037-7930
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840659
City
Gastonia
State/Province
North Carolina
ZIP/Postal Code
28054-7481
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840540
City
Huntersville
State/Province
North Carolina
ZIP/Postal Code
28078-5082
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840523
City
New Bern
State/Province
North Carolina
ZIP/Postal Code
28562-5238
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840621
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27103
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840627
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45236
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840647
City
Dayton
State/Province
Ohio
ZIP/Postal Code
45419-4336
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840646
City
Toledo
State/Province
Ohio
ZIP/Postal Code
43617-1178
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840668
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73104
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840671
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107-5109
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840683
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19140
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840578
City
Anderson
State/Province
South Carolina
ZIP/Postal Code
29621-4822
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840592
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29412-2625
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840528
City
Fort Mill
State/Province
South Carolina
ZIP/Postal Code
29701
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840598
City
North Charleston
State/Province
South Carolina
ZIP/Postal Code
29420
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840660
City
Franklin
State/Province
Tennessee
ZIP/Postal Code
37067
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840546
City
Franklin
State/Province
Tennessee
ZIP/Postal Code
38305
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840553
City
Knoxville
State/Province
Tennessee
ZIP/Postal Code
37909-1161
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840535
City
Baytown
State/Province
Texas
ZIP/Postal Code
77521-2416
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840634
City
Boerne
State/Province
Texas
ZIP/Postal Code
78006-1993
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840566
City
Cypress
State/Province
Texas
ZIP/Postal Code
77429-4696
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840574
City
Kerrville
State/Province
Texas
ZIP/Postal Code
78028-9640
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840551
City
McKinney
State/Province
Texas
ZIP/Postal Code
75069
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840575
City
Mesquite
State/Province
Texas
ZIP/Postal Code
75149-2438
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840663
City
Pearland
State/Province
Texas
ZIP/Postal Code
77584-7401
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840609
City
Plano
State/Province
Texas
ZIP/Postal Code
75025
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840673
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78215-1528
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840681
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 840597
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78258
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840600
City
Sherman
State/Province
Texas
ZIP/Postal Code
75092-7351
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840552
City
Sugar Land
State/Province
Texas
ZIP/Postal Code
77479-3481
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840526
City
Tomball
State/Province
Texas
ZIP/Postal Code
77373
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840631
City
Bellingham
State/Province
Washington
ZIP/Postal Code
98225-1946
Country
United States
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 840562
City
Morgantown
State/Province
West Virginia
ZIP/Postal Code
26505-0423
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 840532
City
Greenfield
State/Province
Wisconsin
ZIP/Postal Code
53228-3467
Country
United States
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32515
City
Buenos Aires
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32565
City
Buenos Aires
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32514
City
Ciudad Autonoma Buenos Aires
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32567
City
Ciudad Autonoma Buenos Aires
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32510
City
Ciudad autónoma de Buenos Aires
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32507
City
Ciudad Autónoma de Buenos Aire
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32503
City
Córdoba
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32509
City
Córdoba
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32508
City
Florencio Varela
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32501
City
Florida
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32562
City
Mar Del Plata
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32505
City
Mendoza
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32511
City
Mendoza
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32513
City
Mendoza
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32506
City
Quilmes
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32553
City
Rosario
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32512
City
San Miguel De Tucumán
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32551
City
San Miguel De Tucumán
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32561
City
San Miguel de Tucumán
Country
Argentina
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 32564
City
San Miguel De Tucumán
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32566
City
San Rafael
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 32556
City
Santa Fe
Country
Argentina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 40502
City
Feldbach
Country
Austria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 40504
City
Grieskirchen
Country
Austria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 40501
City
Linz
Country
Austria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 40503
City
Linz
Country
Austria
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 70553
City
Banja Luka
Country
Bosnia and Herzegovina
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 70555
City
Bihać
Country
Bosnia and Herzegovina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 70554
City
Bijeljina
Country
Bosnia and Herzegovina
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 70557
City
Foča
Country
Bosnia and Herzegovina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 70556
City
Gradiška
Country
Bosnia and Herzegovina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 70560
City
Mostar
Country
Bosnia and Herzegovina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 70562
City
Mostar
Country
Bosnia and Herzegovina
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 70559
City
Sarajevo
Country
Bosnia and Herzegovina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 70561
City
Sarajevo
Country
Bosnia and Herzegovina
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 70551
City
Travnik
Country
Bosnia and Herzegovina
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 70558
City
Trebinje
Country
Bosnia and Herzegovina
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 70563
City
Tuzla
Country
Bosnia and Herzegovina
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 70552
City
Zenica
Country
Bosnia and Herzegovina
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 100535
City
Blagoevgrad
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100534
City
Dimitrovgrad
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100525
City
Gabrovo
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100523
City
Haskovo
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100533
City
Kozloduy
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100527
City
Lovech
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100515
City
Montana
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100532
City
Pernik
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100522
City
Pleven
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100529
City
Plovdiv
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100537
City
Razgrad
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100512
City
Ruse
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100516
City
Ruse
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100536
City
Sevlievo
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100501
City
Sofia
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100509
City
Sofia
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100514
City
Sofia
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100517
City
Sofia
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100518
City
Sofia
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100530
City
Sofia
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100531
City
Sofia
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100538
City
Sofia
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100524
City
Stara Zagora
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100519
City
Vidin
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 100557
City
Vidin
Country
Bulgaria
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 152506
City
Concepcion
Country
Chile
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 152507
City
Quillota
Country
Chile
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 152503
City
Santiago
Country
Chile
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 152504
City
Santiago
Country
Chile
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 152508
City
Santiago
Country
Chile
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 152509
City
Talca
Country
Chile
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 152501
City
Valparaiso
Country
Chile
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 191562
City
Dubrovnik
Country
Croatia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 191552
City
Karlovac
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 191557
City
Osijek
Country
Croatia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 191561
City
Rijeka
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 191563
City
Rijeka
Country
Croatia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 191553
City
Sisak
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 191558
City
Split
Country
Croatia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 191555
City
Zadar
Country
Croatia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 191551
City
Zagreb
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 191554
City
Zagreb
Country
Croatia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 191556
City
Zagreb
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 191559
City
Zagreb
Country
Croatia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 191560
City
Zagreb
Country
Croatia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 203551
City
Brandýs Nad Labem
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 203518
City
Havlíčkův Brod
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 203501
City
Jindřichův Hradec
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 203504
City
Miroslav
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 203516
City
Mladá Boleslav
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 203517
City
Měšice
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 203505
City
Praha
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 203507
City
Praha
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 203513
City
Praha
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 203515
City
Praha
Country
Czechia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 372553
City
Narva
Country
Estonia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 372551
City
Tallinn
Country
Estonia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 372552
City
Tartu
Country
Estonia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276505
City
Berlin
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276506
City
Berlin
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276510
City
Berlin
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276511
City
Berlin
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276515
City
Berlin
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 276556
City
Cottbus
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 276509
City
Darmstadt
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276503
City
Delitzsch
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276504
City
Frankfurt Am Main
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276557
City
Geesthacht
Country
Germany
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 276501
City
Hamburg
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276513
City
Hamburg
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276514
City
Hamburg
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 276558
City
Hannover
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 276517
City
Koblenz
Country
Germany
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 276502
City
Leipzig
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276516
City
Leipzig
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276551
City
Leipzig
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276507
City
Mainz
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276508
City
Munich
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 276518
City
Peine
Country
Germany
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 300506
City
Athens
Country
Greece
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 300504
City
Chortiátis
Country
Greece
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 300501
City
Heraklion
Country
Greece
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 300503
City
Ioannina
Country
Greece
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 300505
City
Thessaloníki
Country
Greece
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 300507
City
Volos
Country
Greece
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348506
City
Balassagyarmat
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348501
City
Budapest
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348505
City
Csorna
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348512
City
Edelény
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348508
City
Gödöllő
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348509
City
Monor
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348507
City
Nyíregyháza
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348513
City
Pécs
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348552
City
Sellye
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348510
City
Szeged
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348503
City
Szombathely
Country
Hungary
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 348515
City
Törökbálint
Country
Hungary
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 376502
City
Ashkelon
Country
Israel
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 376501
City
Be'er Sheva
Country
Israel
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 376511
City
Hadera
Country
Israel
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 376508
City
Haifa
Country
Israel
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 376510
City
Haifa
Country
Israel
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 376503
City
Jerusalem
Country
Israel
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 376506
City
Jerusalem
Country
Israel
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 376507
City
Kfar Saba
Country
Israel
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 376504
City
Ramat Gan
Country
Israel
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 376509
City
Tel Aviv
Country
Israel
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 408556
City
Anyang-si
Country
Korea, Republic of
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 408551
City
Daegu
Country
Korea, Republic of
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 408560
City
Dongjak
Country
Korea, Republic of
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 408554
City
Gwangju
Country
Korea, Republic of
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 408559
City
Haeundae
Country
Korea, Republic of
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 408557
City
Incheon
Country
Korea, Republic of
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 408558
City
Incheon
Country
Korea, Republic of
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 408555
City
Jeonju
Country
Korea, Republic of
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 408552
City
Seoul
Country
Korea, Republic of
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 408553
City
Seoul
Country
Korea, Republic of
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 408561
City
Suwon,Gyeonggi-do
Country
Korea, Republic of
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 371557
City
Balvi
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 371553
City
Daugavpils
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 371554
City
Daugavpils
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 371555
City
Jūrmala
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 371551
City
Riga
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 371552
City
Riga
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 371558
City
Rēzekne
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 371556
City
Rīga
Country
Latvia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 484502
City
Chihuahua
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 484510
City
Chihuahua
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 484505
City
Cordoba
Country
Mexico
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 484506
City
Cuauhtémoc
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 484501
City
Guadalajara
Country
Mexico
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 484507
City
Guadalajara
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 484509
City
Guadalajara
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 484503
City
Monterrey
Country
Mexico
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 484511
City
Monterrey
Country
Mexico
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 484504
City
Veracruz
Country
Mexico
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 528501
City
Beek
Country
Netherlands
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 528504
City
Breda
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 528502
City
Heerlen
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 528505
City
Leeuwarden
Country
Netherlands
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 554504
City
Christchurch
Country
New Zealand
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 554502
City
Hamilton
Country
New Zealand
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 554503
City
Tauranga
Country
New Zealand
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 807555
City
Bitola
Country
North Macedonia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 807559
City
Gevgelija
Country
North Macedonia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 807557
City
Ohrid
Country
North Macedonia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 807553
City
Shtip
Country
North Macedonia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 807552
City
Skopje
Country
North Macedonia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 807554
City
Skopje
Country
North Macedonia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 807556
City
Skopje
Country
North Macedonia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616518
City
Bialystok
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616504
City
Giżycko
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616515
City
Katowice
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616522
City
Katowice
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616514
City
Krakow
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616509
City
Kraków
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616511
City
Kraków
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616519
City
Ostrowiec Świętokrzyski
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616506
City
Poznań
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616508
City
Poznań
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616501
City
Sosnowiec
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616502
City
Torun
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616554
City
Wrocław
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616503
City
Łódź
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 616523
City
Łódź
Country
Poland
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 642510
City
Bacău
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 642551
City
Braşov
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 642506
City
Cluj-Napoca Cluj
Country
Romania
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 642508
City
Cluj-Napoca Cluj
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 642502
City
Cluj-Napoca
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 642504
City
Cluj-Napoca
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 642554
City
Cluj-Napoca
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 642512
City
Cluj
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 642501
City
Constanţa
Country
Romania
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 642509
City
Craiova
Country
Romania
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 642511
City
Craiova
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 642514
City
Iaşi
Country
Romania
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 642503
City
Oradea
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 642513
City
Resca
Country
Romania
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 642507
City
Timisoara
Country
Romania
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 642515
City
Timisoara
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 642505
City
Timişoara
Country
Romania
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 643517
City
Kazan
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643513
City
Moscow
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643528
City
Moscow
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643516
City
Nizhniy Novgorod
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643503
City
Odintsovskiy
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643505
City
Saint Petersburg
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643506
City
Saint Petersburg
Country
Russian Federation
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 643508
City
Saint Petersburg
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643511
City
Saint Petersburg
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643514
City
Saint Petersburg
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643519
City
Saint Petersburg
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643531
City
Saint Petersburg
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643510
City
Saint-Petersburg
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643512
City
Saint-Petersburg
Country
Russian Federation
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 643520
City
Saint-Petersburg
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643504
City
Sankt-Peterburg
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643515
City
Saratov
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643525
City
Saratov
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643521
City
Ulyanovsk
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643502
City
Voronezh
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643524
City
Vsevolozhsk
Country
Russian Federation
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 643507
City
Yaroslavl
Country
Russian Federation
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 643518
City
Yaroslavl
Country
Russian Federation
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 688552
City
Belgrade
Country
Serbia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 688553
City
Belgrade
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688555
City
Belgrade
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688557
City
Belgrade
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688558
City
Belgrade
Country
Serbia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 688559
City
Belgrade
Country
Serbia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 688561
City
Belgrade
Country
Serbia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 688569
City
Belgrade
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688570
City
Jagodina
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688556
City
Kragujevac
Country
Serbia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 688562
City
Leskovac
Country
Serbia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 688554
City
Niš
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688568
City
Niš
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688567
City
Pančevo
Country
Serbia
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 688560
City
Paraćin
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688551
City
Sombor
Country
Serbia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 688564
City
Sremska Kamenica
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688566
City
Sremska Kamenica
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688571
City
Sremska Mitrovica
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 688563
City
Užice
Country
Serbia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 688565
City
Valjevo
Country
Serbia
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 703501
City
Bardejov
Country
Slovakia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 703503
City
Košice
Country
Slovakia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 703502
City
Spišská Nová Ves
Country
Slovakia
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 724503
City
Barcelona
Country
Spain
Individual Site Status
Not yet recruiting
Facility Name
Chiesi Clinical Trial - Site 724501
City
Cordoba
Country
Spain
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 724505
City
Madrid
Country
Spain
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 724551
City
Madrid
Country
Spain
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 724504
City
Majadahonda
Country
Spain
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 724502
City
Zaragoza
Country
Spain
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 792512
City
Adana
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 792510
City
Bornova
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 792507
City
Istanbul
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 792514
City
Kocaeli
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 792513
City
Mersin
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 792506
City
Pamukkale
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 792508
City
Pendik
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 792511
City
Yenişehir
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 792551
City
Çanakkale
Country
Turkey
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804522
City
Dnipro
Country
Ukraine
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 804502
City
Ivano-Frankivs'k
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804504
City
Kharkiv
Country
Ukraine
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 804506
City
Kharkiv
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804509
City
Kharkiv
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804505
City
Kharkov
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804503
City
Kherson
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804511
City
Kiev
Country
Ukraine
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 804520
City
Kremenchuk
Country
Ukraine
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 804501
City
Kyiv
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804508
City
Kyiv
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804512
City
Kyiv
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804516
City
Kyiv
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804518
City
Kyiv
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804521
City
Kyiv
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804527
City
Odessa
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804515
City
Vinnytsia
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804517
City
Vinnytsia
Country
Ukraine
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 804528
City
Zaporizhia
Country
Ukraine
Individual Site Status
Active, not recruiting
Facility Name
Chiesi Clinical Trial - Site 826510
City
Belfast
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 826509
City
Bradford
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 826511
City
London
Country
United Kingdom
Individual Site Status
Recruiting
Facility Name
Chiesi Clinical Trial - Site 826512
City
Rochdale
Country
United Kingdom
Individual Site Status
Recruiting

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

We'll reach out to this number within 24 hrs